Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2004
10/26/2004US6809235 Heat stable mutants of starch biosynthesis enzymes
10/26/2004US6809234 Scarecrow gene, promoter and uses thereof
10/26/2004US6809233 Nucleotide sequences coding transport protein for use as tool in the transport of proteins in cells
10/26/2004US6809232 Methods and compositions for the introduction of molecules into cells
10/26/2004US6809201 Intercalator suitable for electrochemical detection of double strand DNAs and a process for preparing thereof
10/26/2004US6809194 For regulating cell growth/tumors; serine/threonine kinases (atk3)
10/26/2004US6809193 Antisense oligonucleotide compositions and methods for the modulation of JNK proteins
10/26/2004US6809191 GM-CSF nucleic acid sequences
10/26/2004US6809189 Apoptin-associating protein
10/26/2004US6809185 Created by heterodimerization of immunoglobulin domains; have two or more antigen binding parts; for diagnosis/treatment of human diseases
10/26/2004US6809183 Polypeptide for use in the generation of disease resistant plants
10/26/2004US6809181 Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide
10/26/2004US6809180 Compositions and methods for screening antimicrobials
10/26/2004US6809178 Polypeptide for use in the treatment of addison's disease
10/26/2004US6809175 Cadherin derived growth factor and its use
10/26/2004US6809078 Nucleotide sequences coding polypeptide use in the generation of insect resistant plants; biological pest control
10/26/2004US6808926 Histone deacetylase chimeric constructs; transgenic cells/seeds/plants
10/26/2004US6808925 Detecting preferential enzymatic polypeptide in cells; obtain cells, transform, culture cells, recover cells expressing preferential polypeptide, propagate cells
10/26/2004US6808923 Episomally replicating lentiviral vectors
10/26/2004US6808922 Retroviral vectors comprising a functional splice donor site and a functional splice acceptor site
10/26/2004US6808921 Vectors for gene mutagenesis and gene discovery
10/26/2004US6808915 Cell-wall degrading enzyme variants
10/26/2004US6808914 Nucleotide sequences coding polypeptide for use in the biosynthesis of amino acid for use in human medicine and animal nutrients
10/26/2004US6808913 Comprises genetically engineered subtilisin for improved washing abilty of deteregents
10/26/2004US6808912 For diagnosis/therapy of inflammation, cancer, arteriosclerosis, and psoriasis
10/26/2004US6808906 Directionally cloned random cDNA expression vector libraries, compositions and methods of use
10/26/2004US6808905 Lentiviral vectors encoding clotting factors for gene therapy
10/26/2004US6808904 Herbicide-tolerant protox genes produced by DNA shuffling
10/26/2004US6808902 Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
10/26/2004US6808900 Test kits; genetic engineering
10/26/2004US6808899 G protein-coupled receptor protein for use in treatment of nervous system disorders
10/26/2004US6808898 Low oxygen affinity mutant hemoglobins
10/26/2004US6808896 Generation of a genetically engineered cell; obtain cell, incubate with expression vector, transform, propagate cells, express vector, recover cell expressing reporter molecule
10/26/2004US6808893 Glutamate transporter associated proteins and methods of use thereof
10/26/2004US6808892 Inositolphosphoryl-ceramide (ipc) synthase; antifungal targets; drug screening; genetic engineering
10/26/2004US6808885 Triple-stranded DNA, method of forming the same and southern hybridization
10/26/2004US6808884 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/26/2004US6808883 Automatable rapid test for detection of cancer, based on telomerase (hTC) mRNA with specific primers and probes
10/26/2004US6808882 Isolating preferential nucleotide sequences; obtain nucleotide sequence samples, encapsulate into microcapsules, monitor gene expression activities
10/26/2004US6808881 For detecting specific haplotypes; for prognosis/diagnosis; restriction site alleles
10/26/2004US6808880 Method for detecting polynucleotides encoding telomerase
10/26/2004US6808879 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample
10/26/2004US6808878 Genes from the 20Q13 amplicon and their uses
10/26/2004US6808876 Cellular regulators of infectious agents and methods of use
10/26/2004US6808712 Imunogenic a beta fragment linked to immunoglobulin carrier to form conjugate; adjuvant comprising antibodies to a beta fragment enhances immune response; alzheimer*s disease treatment
10/26/2004US6808711 Immunologically active proteins from Borrelia burgdorferi, nucleic acids which encode them, and their use in test kits and as vaccines
10/26/2004US6808710 Contacting cell expressing pd-1 with binding agent; genetic transduction of negative signal
10/26/2004US6808709 Immunoglobulins containing protection proteins and their use
10/26/2004US6808704 Removing nuclear dna from recipient oocyte to form nuclear transfer agent; activating and culturing to generate non-human embryo; injecting into donor mammal; examining site for teratoma and signs of rejection
10/26/2004CA2328060C Gene any-rf, dormancy-control substance and method for preparing the same as well as cell-control agent for biological cells
10/26/2004CA2286573C Nucleic acid archiving
10/26/2004CA2263888C Methods and compositions for the detection of cervical cancer
10/26/2004CA2261999C Invertase inhibitor
10/26/2004CA2177616C Preparation and use of immunoconjugates
10/26/2004CA2142973C A methodology for selecting superagonists, antagonists and superantagonists of hormones whose receptor complex includes gp 130
10/26/2004CA2137237C Purified forms of dnase
10/26/2004CA2131161C Production of aspergillus niger catalase-r
10/26/2004CA1341461C T helper cell growth factor
10/24/2004CA2462747A1 Breast cancer prognostics
10/21/2004WO2004090542A1 Protein array and process for producing the same
10/21/2004WO2004090532A1 Method of determining xenograft responses
10/21/2004WO2004090155A2 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger
10/21/2004WO2004090153A2 Polymerase inhibitor and method of using same
10/21/2004WO2004090149A1 Process for the production of l-amino acids using strains of the enterobacteriaceae family which contain an enhance yfidd orf and/or pfld gene
10/21/2004WO2004090146A1 Delivery of nucleic acids into eukaryotic genomes using in vitro assembled mu transposition complexes
10/21/2004WO2004090145A2 Compounds and methods to enhance raav transduction
10/21/2004WO2004090144A2 Mthp promoter element
10/21/2004WO2004090143A2 Modulation of cytokinin activity in plants
10/21/2004WO2004090142A2 Plants having modified growth characteristics and method for making the same
10/21/2004WO2004090141A2 Method to increase stress tolerance in plants
10/21/2004WO2004090140A2 Methods and means for increasing the tolerance of plants to stress conditions
10/21/2004WO2004090139A1 Method for the construction of randomized gene sequence libraries in cells
10/21/2004WO2004090138A1 Method for the production of vitamin b12
10/21/2004WO2004090137A1 Novel gene
10/21/2004WO2004090136A1 Chalcone synthase dihydroflavonol 4-reductase and leucoanthocyanidine reductase from clover, medic ryegrass or fescue
10/21/2004WO2004090135A2 Cytokine polypeptides and antibodies containing a signal sequence for the attachement of glycosylphosphatidylinositol
10/21/2004WO2004090134A1 Oligoribonucleotide sequence homologous to a cdna region which codes for the human cd40 receptor and duplex oligoribonucleotides, vectors, pharmaceutical compositions and uses associated thereto
10/21/2004WO2004090133A2 Method of rna cleavage and recombination
10/21/2004WO2004090132A2 Method for isolating nucleic acids
10/21/2004WO2004090131A1 Inducible site-directed mutagenesis through conditional gene rescue
10/21/2004WO2004090130A1 Novel vector and method of constructing transformant plant using the vector
10/21/2004WO2004090127A1 Agar-digesting enzyme and utilization thereof
10/21/2004WO2004090125A2 Method for producing l-amino acid using bacteria having enhanced expression of the gene pcka
10/21/2004WO2004090124A2 Sequences encoding s-hydroxynitril lyases and their use in methods for the production of cyanohydrins
10/21/2004WO2004090123A2 Δ-4 desaturases from euglena gracilis, expressing plants, and oils containing pufa
10/21/2004WO2004090122A1 Tongue epithelium-origin cell line kt-1 and use thereof
10/21/2004WO2004090119A1 A method of producing nuclear transfer embryonic stem cell by somatic cell nuclear transplantation technique
10/21/2004WO2004090115A2 Renilla gfp mutants with increased fluorescent intensity and special shift
10/21/2004WO2004090110A2 Compositions and methods for the control, differentiation and/or manipulation of pluripotent cells through a gamma-secretase signaling pathway
10/21/2004WO2004090108A2 Irna conjugates
10/21/2004WO2004090107A2 Endosomolytic polymers
10/21/2004WO2004090105A2 Modified polynucleotides for use in rna interference
10/21/2004WO2004090103A2 Identification of novel nogo-receptors and methods related thereto
10/21/2004WO2004090095A2 Generation of human regulatory t cells by bacterial toxins for the treatment of inflammatory disorders
10/21/2004WO2004090094A2 L-carnitin dehydrogenases, their derivatives and method for producing substituted (s) alkanols
10/21/2004WO2004089986A1 Antimicrobial peptide from transferrin family
10/21/2004WO2004089979A2 Adp-ribosylating toxin from listeria monocytogenes
10/21/2004WO2004089977A1 Immobilized protein and process for producing the same
10/21/2004WO2004089815A1 Member for molecular elaboration
10/21/2004WO2004089423A2 Pharmico-gene theraphy of epithelial sodium channel associated disoders